Search Results - "Brüggemann, Roger"

Taskforce report on the diagnosis and clinical management of COVID-19 associated pulmonary aspergillosis by Verweij, Paul E., Brüggemann, Roger J. M., Azoulay, Elie, Bassetti, Matteo, Blot, Stijn, Buil, Jochem B., Calandra, Thierry, Chiller, Tom, Clancy, Cornelius J., Cornely, Oliver A., Depuydt, Pieter, Koehler, Philipp, Lagrou, Katrien, de Lange, Dylan, Lass-Flörl, Cornelia, Lewis, Russell E., Lortholary, Olivier, Liu, Peter-Wei Lun, Maertens, Johan, Nguyen, M. Hong, Patterson, Thomas F., Rijnders, Bart J. A., Rodriguez, Alejandro, Rogers, Thomas R., Schouten, Jeroen A., Wauters, Joost, van de Veerdonk, Frank L., Martin-Loeches, Ignacio

“…Purpose Invasive pulmonary aspergillosis (IPA) is increasingly reported in patients with severe coronavirus disease 2019 (COVID-19) admitted to the intensive…”
Get full text

Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinion by Verweij, Paul E., Rijnders, Bart J. A., Brüggemann, Roger J. M., Azoulay, Elie, Bassetti, Matteo, Blot, Stijn, Calandra, Thierry, Clancy, Cornelius J., Cornely, Oliver A., Chiller, Tom, Depuydt, Pieter, Giacobbe, Daniele Roberto, Janssen, Nico A. F., Kullberg, Bart-Jan, Lagrou, Katrien, Lass-Flörl, Cornelia, Lewis, Russell E., Liu, Peter Wei-Lun, Lortholary, Olivier, Maertens, Johan, Martin-Loeches, Ignacio, Nguyen, M. Hong, Patterson, Thomas F., Rogers, Thomas R., Schouten, Jeroen A., Spriet, Isabel, Vanderbeke, Lore, Wauters, Joost, van de Veerdonk, Frank L.

“…Purpose Invasive pulmonary aspergillosis is increasingly reported in patients with influenza admitted to the intensive care unit (ICU). Classification of…”
Get full text

Effect of Haloperidol on Survival Among Critically Ill Adults With a High Risk of Delirium: The REDUCE Randomized Clinical Trial by van den Boogaard, Mark, Slooter, Arjen J. C, Brüggemann, Roger J. M, Schoonhoven, Lisette, Beishuizen, Albertus, Vermeijden, J. Wytze, Pretorius, Danie, de Koning, Jan, Simons, Koen S, Dennesen, Paul J. W, Van der Voort, Peter H. J, Houterman, Saskia, van der Hoeven, J. G, Pickkers, Peter, van der Woude, Margaretha C. E, Besselink, Anna, Hofstra, Lieuwe S, Spronk, Peter E, van den Bergh, Walter, Donker, Dirk W, Fuchs, Malaika, Karakus, Attila, Koeman, M, van Duijnhoven, Mirella, Hannink, Gerjon

“…IMPORTANCE: Results of studies on use of prophylactic haloperidol in critically ill adults are inconclusive, especially in patients at high risk of delirium…”
Get full text

Pharmacokinetics and Pharmacodynamics of Posaconazole by Chen, Lu, Krekels, Elke H. J., Verweij, Paul. E., Buil, Jochem B., Knibbe, Catherijne A. J., Brüggemann, Roger J. M.

“…Posaconazole is typically used for preventing invasive yeast and mold infections such as invasive aspergillosis in high-risk immunocompromised patients. The…”
Get full text

Cost Evaluation of Dried Blood Spot Home Sampling as Compared to Conventional Sampling for Therapeutic Drug Monitoring in Children by Martial, Lisa C, Aarnoutse, Rob E, Schreuder, Michiel F, Henriet, Stefanie S, Brüggemann, Roger J M, Joore, Manuela A

“…Dried blood spot (DBS) sampling for the purpose of therapeutic drug monitoring can be an attractive alternative for conventional blood sampling, especially in…”
Get full text

Aspergillus Test Profiles and Mortality in Critically Ill COVID-19 Patients by Ergün, Mehmet, Brüggemann, Roger J M, Alanio, Alexandre, Dellière, Sarah, van Arkel, Andreas, Bentvelsen, Robbert G, Rijpstra, Tom, van der Sar-van der Brugge, Simone, Lagrou, Katrien, Janssen, Nico A F, Buil, Jochem B, van Dijk, Karin, Melchers, Willem J G, Reijers, Monique H E, Schouten, Jeroen A, Wauters, Joost, Cordey, Alan, Soni, Shuchita, White, P Lewis, van de Veerdonk, Frank L, Verweij, Paul E

“…The literature regarding COVID-19-associated pulmonary aspergillosis (CAPA) has shown conflicting observations, including survival of CAPA patients not…”
Get full text

Drug‐drug interactions between triazole antifungal agents used to treat invasive aspergillosis and immunosuppressants metabolized by cytochrome P450 3A4 by Groll, Andreas H., Townsend, Robert, Desai, Amit, Azie, Nkechi, Jones, Mark, Engelhardt, Marc, Schmitt‐Hoffman, Anne‐Hortense, Brüggemann, Roger J. M.

“…Patients undergoing treatment with immunosuppressant drugs following solid organ or hematopoietic stem cell transplantation are at particular risk for…”
Get full text

Clinical Relevance of the Pharmacokinetic Interactions of Azole Antifungal Drugs with Other Coadministered Agents by Brüggemann, Roger J. M., Alffenaar, Jan-Willem C., Blijlevens, Nicole M. A., Billaud, Eliane M., Kosterink, Jos G. W., Verweij, Paul E., Burger, David M., Saravolatz, Louis D.

“…There are currently a number of licensed azole antifungal drugs; however; only 4 (namely, fluconazole, itraconazole, posaconazole, and voriconazole) are used…”
Get full text

Efficacy of Posaconazole against Three Clinical Aspergillus fumigatus Isolates with Mutations in the cyp51A Gene by MAVRIDOU, Eleftheria, BRÜGGEMANN, Roger J. M, MELCHERS, Willem J. G, MOUTON, Johan W, VERWEIJ, Paul E

“…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
Get full text

Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance by Koehler, Philipp, Bassetti, Matteo, Chakrabarti, Arunaloke, Chen, Sharon C A, Colombo, Arnaldo Lopes, Hoenigl, Martin, Klimko, Nikolay, Lass-Flörl, Cornelia, Oladele, Rita O, Vinh, Donald C, Zhu, Li-Ping, Böll, Boris, Brüggemann, Roger, Gangneux, Jean-Pierre, Perfect, John R, Patterson, Thomas F, Persigehl, Thorsten, Meis, Jacques F, Ostrosky-Zeichner, Luis, White, P Lewis, Verweij, Paul E, Cornely, Oliver A

“…Severe acute respiratory syndrome coronavirus 2 causes direct damage to the airway epithelium, enabling aspergillus invasion. Reports of COVID-19-associated…”
Get full text

Pharmacokinetics and Target Attainment of Antibiotics in Critically Ill Children: A Systematic Review of Current Literature by Hartman, Stan J. F., Brüggemann, Roger J., Orriëns, Lynn, Dia, Nada, Schreuder, Michiel F., de Wildt, Saskia N.

“…Background Pharmacokinetics (PK) are severely altered in critically ill patients due to changes in volume of distribution (Vd) and/or drug clearance (Cl). This…”
Get full text

Prophylaxis Against Invasive Fungal Disease for Neutropenic Children and Young Adults by de Lange, Dylan W, Brüggemann, Roger J. M

Get full text

Obesity and drug pharmacology: a review of the influence of obesity on pharmacokinetic and pharmacodynamic parameters by Smit, Cornelis, De Hoogd, Sjoerd, Brüggemann, Roger J M, Knibbe, Catherijne A J

“…The rising prevalence of obesity confronts clinicians with dosing problems in the (extreme) overweight population. Obesity has a great impact on key organs…”
Get more information

High Variability in Isavuconazole Unbound Fraction in Clinical Practice: A Call to Reconsider Pharmacokinetic/Pharmacodynamic Targets and Breakpoints by Jansen, Anouk M. E., ter Heine, Rob, Verweij, Paul E., Brüggemann, Roger J. M.

“…Isavuconazole exposure–response relationships have been studied with a focus on total rather than unbound exposure, assuming a constant unbound fraction of 1%…”
Get full text

Pharmacodynamics of isavuconazole in an Aspergillus fumigatus mouse infection model by Seyedmousavi, Seyedmojtaba, Brüggemann, Roger J M, Meis, Jacques F, Melchers, Willem J G, Verweij, Paul E, Mouton, Johan W

“…Azole resistance is an emerging problem in Aspergillus fumigatus which translates into treatment failure. Alternative treatments with new azoles may improve…”
Get full text

Clinical Pharmacokinetics, Pharmacodynamics, Safety and Efficacy of Liposomal Amphotericin B by Groll, Andreas H, Rijnders, Bart J A, Walsh, Thomas J, Adler-Moore, Jill, Lewis, Russell E, Brüggemann, Roger J M

“…Abstract Since its introduction in the 1990s, liposomal amphotericin B (LAmB) continues to be an important agent for the treatment of invasive fungal diseases…”
Get full text

Tobramycin Clearance Is Best Described by Renal Function Estimates in Obese and Non-obese Individuals: Results of a Prospective Rich Sampling Pharmacokinetic Study by Smit, Cornelis, Wasmann, Roeland E., Wiezer, Marinus J., van Dongen, Hendricus P. A., Mouton, Johan W., Brüggemann, Roger J. M., Knibbe, Catherijne A. J.

“…Purpose Tobramycin is an aminoglycoside antibiotic of which the 24 h exposure correlates with efficacy. Recently, we found that clearance of the aminoglycoside…”
Get full text

International expert opinion on the management of infection caused by azole-resistant Aspergillus fumigatus by Verweij, Paul E, Ananda-Rajah, Michelle, Andes, David, Arendrup, Maiken C, Brüggemann, Roger J, Chowdhary, Anuradha, Cornely, Oliver A, Denning, David W, Groll, Andreas H, Izumikawa, Koichi, Kullberg, Bart Jan, Lagrou, Katrien, Maertens, Johan, Meis, Jacques F, Newton, Pippa, Page, Iain, Seyedmousavi, Seyedmojtaba, Sheppard, Donald C, Viscoli, Claudio, Warris, Adilia, Donnelly, J. Peter

“…Abstract An international expert panel was convened to deliberate the management of azole-resistant aspergillosis. In culture-positive cases, in vitro…”
Get full text

Population Pharmacokinetics of Total and Unbound Isavuconazole in Critically Ill Patients: Implications for Adaptive Dosing Strategies by Jansen, Anouk M. E., Mertens, Beatrijs, Spriet, Isabel, Verweij, Paul E., Schouten, Jeroen, Wauters, Joost, Debaveye, Yves, ter Heine, Rob, Brüggemann, Roger J. M.

“…Background and Objectives Isavuconazole is a broad-spectrum antifungal agent for the management of invasive fungal disease. Optimised drug exposure is critical…”
Get full text

Posaconazole for prevention of invasive pulmonary aspergillosis in critically ill influenza patients (POSA-FLU): a randomised, open-label, proof-of-concept trial by Vanderbeke, Lore, Janssen, Nico A. F., Bergmans, Dennis C. J. J., Bourgeois, Marc, Buil, Jochem B., Debaveye, Yves, Depuydt, Pieter, Feys, Simon, Hermans, Greet, Hoiting, Oscar, van der Hoven, Ben, Jacobs, Cato, Lagrou, Katrien, Lemiale, Virginie, Lormans, Piet, Maertens, Johan, Meersseman, Philippe, Mégarbane, Bruno, Nseir, Saad, van Oers, Jos A. H., Reynders, Marijke, Rijnders, Bart J. A., Schouten, Jeroen A., Spriet, Isabel, Thevissen, Karin, Thille, Arnaud W., Van Daele, Ruth, van de Veerdonk, Frank L., Verweij, Paul E., Wilmer, Alexander, Brüggemann, Roger J. M., Wauters, Joost

“…Purpose Influenza-associated pulmonary aspergillosis (IAPA) is a frequent complication in critically ill influenza patients, associated with significant…”
Get full text